Back to results
US 2013/0253175 A1Published application
Gram-positive bacteria specific binding compounds
AssigneeGenentech, Inc.
InventorsTim BEAUMONT, Mark Jeroen KWAKKENBOS, Eric J. BROWN, John Hiroshi MORISAKI, Wouter L.W. HAZENBOS, Sanjeev MARIATHASAN, Kimberly KAJIHARA, Yi XIA
Life of this patent
Estimating the term…
Abstract
The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.
Claims27
1-43. (canceled)
An antibody or functional part thereof capable of binding a serine-aspartate (SD) repeat-dependent epitope.
Dependencies are inferred from the claim text.